RxDoctor Payments Data

Jason Showmaker, MD

Otolaryngology · Merriam, KSNPI 1609187871

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $412 and has fallen 53.4% since, to $192 in 2025.

$1,857in general payments, 2019–2025

Across 65 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$421
  • Intersect ENT, Inc.$215
  • C2dx, Inc$169
  • Stryker$151
  • Acclarent, Inc$149
  • Regeneron Healthcare Solutions, Inc.$148
  • plus $604 from 13 others

What the payments were for

  • Food & beverage$1,857100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,857 in reported general payments places this provider in the 60th percentile of 87 otolaryngology providers in Kansas.

See all otolaryngology providers in Kansas

Medicare billing

Part B allowed, 2024
$149,007
Medicare patients
359
Services billed
2,540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$40,802
Ipratropium Bromide125$3,575
Doxycycline Hyclate77$953
Azelastine Hcl15$556
Oxycodone Hcl62$545
Ciprofloxacin Hcl19$317
Levothyroxine Sodium46$306
Triamcinolone Acetonide16$282
Mupirocin49$245
Cefdinir11$214
Montelukast Sodium20$87
Prednisone15$47
Metoclopramide Hcl12$24

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Merriam

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →